Italy Intravenous Solutions Market Size & Outlook
Italy intravenous solutions market, 2018-2030 (US$M)
Related Markets
Italy intravenous solutions market highlights
- The Italy intravenous solutions market generated a revenue of USD 346.3 million in 2023 and is expected to reach USD 574.0 million by 2030.
- The Italy market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2023 | USD 346.3 million |
| Market revenue in 2030 | USD 574.0 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global intravenous solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany intravenous solutions market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,011.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 65.61% in 2023. Horizon Databook has segmented the Italy intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
Italy’s intravenous solution market is driven by the rising geriatric population, the growing prevalence of chronic diseases, and the ongoing trend of personalized or lifestyle nutrition. An increase in the number of initiatives to promote clinical nutrition is also positively impacting the market.
The burden of chronic diseases in the country is increasing. According to WHO, CVDs are among the major chronic diseases causing death in the country. According to the Institute for Health Metrics and Evaluation (IHME), in 2019, ischemic heart disease is a leading noncommunicable disease in terms of mortality in the country.
The growing adoption of personalized nutrition is also expected to increase the demand for intravenous solutions. The presence of various organizations that are creating awareness about clinical nutrition is also one of the key drivers of the market.
Reasons to subscribe to Italy intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into Italy intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy intravenous solutions market size, by product, 2018-2030 (US$M)
Italy Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
